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Accepted 2 March 2016A label-free electrochemical immunoassay that combines DNA-directed immobilization (DDI)with electrochem-
ical impedance spectroscopy (EIS) onmicrowire sensors is reported for the detection of C-reactive protein (CRP).
CRP is an acute-phase protein that is strongly correlatedwith systemic inﬂammation. Since inﬂammation plays a
role in pathogenesis of cardiovascular diseases, CRP can be used to predict the likelihood of coronary events. To
demonstrate the new chemistry, 25-μm Au electrodes were modiﬁed with single strand DNA (ssDNA) and ex-
posed to a solution containing complementary ssDNA conjugated to monoclonal anti-CRP. The charge-transfer
resistance of the [Fe(CN)6]
3−/4− redox couplewas used to determine the CRP concentration after binding. A step-
wise increase in the charge transfer resistancewas observed using EIS for eachmodiﬁcation step, ssDNA, ssDNA-
anti-CRP hybridization and the ﬁnal CRP capture. Cyclic voltammetry (CV)was used to verify the EIS results, and
showed an increase in peak potential splitting in a similar stepwise manner for each modiﬁcation step. Finally,
ﬂuorescence microscopy was used to conﬁrm the DNA hybridization and CRP binding. Standard addition of
CRP revealed that EIS could be used to detect CRP at clinically relevant levels in serum samples. This new form
of electrochemical DNA immunoassay (eDI) has signiﬁcant potential as a simple, label-free sensor for proteins
in microﬂuidic devices.
© 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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C-reactive protein (CRP) is an acute-phase protein that has beenwide-
ly associated with medical diagnostics in the routine laboratory as a bio-
marker for acute infection or inﬂammation [1–4] with clinical reference
intervals of 1 μg/mL [5]. In the case of acute inﬂammation, however, levels
can increase 1000-fold above baseline levels [6,7]. Since inﬂammation
plays a role in pathogenesis of cardiovascular disease, CRP can be used
to predict the likelihood of coronary events [8–11]. As a result of its
importance, many CRP detection methods have been reported in-
cluding immunoturbidimetry [12,13], immunoagglutination [14,15]
and enzyme-linked immunosorbent assay (ELISA) [16–18]. However,
these techniques have disadvantages including requiring large (mL)
volumes of costly reagents and expensive automated equipment. As a
result, most CRP measurements are done in centralized laboratories
resulting in signiﬁcant time delays for patient feedback.
One solution for reducing feedback time is to perform point-of-care
measurements using biosensors. Biosensors play an important role in
point-of-care diagnosis, utilizing rapid, low-cost and accurate detectionapaisal),
. This is an open access article undertechniques as typiﬁed by the handheld glucometer. Many techniques
have been developed for CRP detection, including biosensors [1,5,
19–21], point-of-care-testing platforms [2,22–25], immunosensors
[27,28], and electrochemical detection systems [26,29–32]. Among
these techniques, electrochemistry is widely used as a detection tech-
nique because of its high accuracy and sensitivity coupled with the
low cost and portability of the associated instrumentation.
DNA hybridization-directed antibodies immobilization biosen-
sors for highly sensitive and selective detection have been reported
[33–38]. DNA is useful as a capture agent for biosensors because of
the sequence speciﬁc nature of hybridization coupled with the
strong interactions that exist in hybridized DNA. It can be modiﬁed
chemically with functional groups to improve its properties. More-
over, DNA can also be combined with antibodies [39,40]. Thus, DNA
is widespread for use in biosensor applications.
We report a new electrochemical biosensor for CRP detection as
part of a ﬁrst step in the development of simple, multi-electrode
microﬂuidic clinical diagnostic tools. One of the biggest challenges
with multi-analyte electrochemical biosensors is localization of the
afﬁnity agents on individual electrodes. One elegant solution to this
problem is the use of DNA hybridization to direct localization of an-
tibodies or other afﬁnity agents [41]. These techniques, referred to
as DNA Zipcoding or DNA-Directed Immobilization (DDI) havethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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tection but not with electrochemical immunoassays. This report de-
tailing the development of an electrochemical DNA immunoassay
(eDI), is made possible by selective modiﬁcation of Au microwires in
an electrochemical cell. The use of microwire electrodes for electro-
chemical detection in conjunction with paper-based analytical devices
has been reported recently [42]. Au is used because it is easily modiﬁed
with thiolated DNA [43,44]. Oncemodiﬁed, the electrode can be readily
blocked to reduce non-speciﬁc interactions using mercaptohexanol
(MCH) [44–46]. After modiﬁcation with the ssDNA, an antibody modi-
ﬁed with complementary ssDNA is added, resulting in an electrode
modiﬁed with the target antibody. Finally, binding is measured using
Electrochemical Impedance Spectroscopy (EIS). EIS is a common elec-
trochemical technique capable of quantifying surface binding [47,48].
EIS has been used to detect biomolecular events including protein–
protein interactions [49,50], DNA hybridization [51–53], DNA–RNA
[54] and DNA-protein interactions [55–58].
In the current report, a label-free electrochemical biosensor
based on DNA-directed immobilization was exploited for CRP detec-
tion. A 25-μm diameter Au wire was utilized to fabricate working
electrodes in a 3-mm PDMS-based electrochemical cell, using an Ag
wire as the common reference electrode. ssDNA was immobilized
on the gold microwire electrode surface via thiol chemistry with
MCH as the blocking agent. The electrode was then modiﬁed using
a complementary strand of ssDNA conjugated to monoclonal anti-
CRP (ssDNA-anti-CRP) via hybridization with the ssDNA previously
bound to the Au electrode surface. The anti-CRP was able to speciﬁ-
cally capture CRP in different samples with signal changes after
ssDNA modiﬁcation, ssDNA-anti-CRP hybridization, and CRP capture
monitored by EIS and cyclic voltammetry (CV). Finally, CRP was
quantiﬁed out of human serum using EIS and showed good correla-
tion with known levels.
2. Materials and methods
2.1. Materials and chemicals
Gold microwire was obtained from California Fine Wire Company
(Grover Beach, CA). SH-ssDNA probe (5′−/5ThioMC6-D/TTT TTT TTTFig. 1. Schematic diagramof electrodemodiﬁcation processes and expectedEIS results. From left
with MCH, electrode hybridized with ssDNA-anti-CRP hybridization, and CRP captured on theTCC TGC GTC GTT TAA GGA AGT AC-3′) and NH-ssDNA (5′−/
5AmMC6/GTA CTT CCT TAA ACG ACG CAG G-3′) were synthesized by
Integrated DNA Technologies (Coralville, IA). C-reactive protein and
CRP monoclonal antibody were purchased from Fitzgerald Industries
(Acton, MA). Ethylenediaminetetraacetic acid (EDTA), 6-mercapto-1-
hexanol (MCH), 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide
(EDC) and bovine serum albumin (BSA) were purchased from
Sigma Aldrich (St. Louis, MO). N-(2-Hydroxyethyl)succinimide
(NHS) was product of Pierce (Rockford, IL). Potassium Phosphate
Monobasic (KH2PO4) was a product of Fisher Scientiﬁc (Pittsburg,
PA). Tris was manufactured from J.T. Baker (Center Valley, PA). Sodi-
um chloride was product of Macron Chemicals (St. Louis, MO). Fluo-
rescein isothiocyanate (FITC) was product of Thermo Scientiﬁc
(Pittsburg, PA). Potassium ferricyanide was from Fisher Scientiﬁc
and potassium ferrocyanide was from Mallinckrodt (St. Louis, MO).
All chemicals were used as received.
2.2. Electrode fabrication
The electrochemical cell consisted of three 25-μm gold microwires,
used as working electrodes, and a single Ag wire (25-μm), used as the
reference electrode. Multiple working electrodes were added to allow
multiple measurements of the same target analyte in each experiment
for improved statistics. The electrodes were placed on a ﬂat piece of
PDMS, and a second piece of PDMS, containing a 3 mm diameter open-
ing, was sealed over the electrodes using plasma bonding. Braided Cu
wires were connected to each gold microwire using silver paint to pro-
vide robust electrical contacts and held in place using epoxy. The Ag
wire was used as the common reference electrode against all three
working electrodes.
2.3. Electrode modiﬁcation
The DNA probe length was 32 bases. The previous work reported
that varied length of DNA (8–48 bases) could be immobilized on solid
surface via thiol group although the surface coverage begins to decrease
with probe length [59]. Probe was tethered with thiol group through a
5′ poly(T) tail in order to facilitate the immobilization of the designed
DNA probe on Au microwire. The poly(T) tails length allows probe toto right, bare electrode, electrodemodiﬁedwith thiolated ssDNAmodiﬁcation and blocked
Au microwire electrode.
Fig. 2. Cyclic voltammogram (CV) and electrochemical impedance spectroscopy (EIS)
measurement results for electrode modiﬁcation. (A) ――― bare gold, .......... ssDNA self-
assembled monolayer on gold, ˗˗˗ ssDNA-anti-CRP hybridized to the probe, ______ and
CRP capture with anti-CRP. (B) Nyquist plot ● bare gold, ○ ssDNA self-assembled
monolayer on gold, ▾ ssDNA-anti-CRP hybridized to the probe, and Δ 6.25 mg/L CRP, ■
12.5 mg/L CRP and □ 25 mg/L CRP at 0.1 Hz–100 kHz frequency range, amplitude at
0.01 V with the potential at 0.2 V in 5 mM [Fe(CN)6]3−/4−.
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strand.
To modify the electrode surface, the gold electrodes were cleaned
using previously published methods [60,61]. Electrodes were electro-
chemically polished by potential cycling between−1.0 V to +1.0 V at
100 mV/s for ten cycles in KOH (50 mM). Next, 50 μL of SH-ssDNA
(1 μM) in KH2PO4 (1 M, pH 3.8) was added to the well containing the
working electrodes for 1 h at room temperature (22 ± 2 °C). In this
step, the DNA probe was immobilized on microwire via thiol group.
The remaining ssDNAwas removed by thoroughwashingwith distilled
water. To block the electrode surface, MCH (1 mM) was added to the
working electrodes and incubated for 1 h at room temperature (22 ±
2 °C). Excess MCH was removed by extensive washing with deionized
water. After modiﬁcation, the electrodes were used for subsequent
measurements of CRP binding.
2.4. ssDNA-anti-CRP hybridization and CRP detection on gold electrode
Anti-CRP monoclonal antibody was modiﬁed with the complemen-
tary ssDNA using EDC/NHS bioconjugation according to established
methods [62]. Brieﬂy, anti-CRP was activated in EDC/NHS solution for
15 min (0.1 mg/mL of EDC and 0.6 mg/mL of NHS in 0.1 M MES, 0.5 M
NaCl, pH 6.0). Next, the activated anti-CRP was combined with amine-
modiﬁed single strand DNA (NH-ssDNA) at a 1:1 ratio and reacted for
2 h at room temperature (22 ± 2 °C). Finally, the solution was ﬁltered
using a centrifugal molecular weight cuttoff ﬁlter (30 kDa cutoff,
14,500 rpm, 5 min) to remove unreacted EDC/NHS/anti-CRP and rinsed
three times using PBS buffer. ssDNA-anti-CRP (1 μM) diluted in TE buff-
er (10 mM Tris–HCl, 1 mM EDTA, 1 M NaCl) was added to the well and
allowed to hybridize with SH-ssDNA bound to the Au microwire elec-
trodes for 1 h, resulting in an electrode surface modiﬁed with the anti-
CRP. Then, an electrode was rinsed with PBS and deionized water to re-
move unhybridized DNA. Following this, the electrode surface was sub-
merged in a BSA solution (5% w/v in PBS) for 20 min to minimize non-
speciﬁc adsorption following bywashingwith PBS and deionizedwater.
Then, a sample containing CRP was incubated on electrode surface for
10 min to complete the reaction. After rinsed step, the EIS spectra was
recorded. Fig. 1 shows a schematic representation of the electrodemod-
iﬁcation steps and resulting changes in EIS spectra.
2.5. Electrochemical measurements
All electrochemical experiments were carried out using the Au
microwire working electrodes (WE) with a Ag common reference elec-
trode (RE). Electrochemical experiments were performed on a CHI-660
electrochemical workstation (CH Instruments). Cyclic voltammetry
(CV) and EIS were carried out in 5 mM [Fe(CN)6]3−/4- prepared in PBS
buffer (pH 7.4, containing 0.1 M KCl). Unless otherwise stated, cyclic
voltammetry was performed at 100 mV/s and cycled from−0.6 V to
0.8 V. EIS was recorded using 0.1 Hz–100 kHz frequency range. The am-
plitude was 0.01 V with the potential at 0.2 V. Data were plotted in
Nyquist plots. For standard CRP detection, commercial human serum
control spiked with various CRP concentrations was used to generate
the calibration curve. CRP in serum control was measured by EIS using
the optimized conditions. For blind sample studies, samples were pre-
pared as same as standard CRP by a laboratory coworker. The concentra-
tion of CRP for each unknown was not reported until the sample was
analyzed by EIS.
3. Results and discussion
3.1. CRP detection by cyclic voltammetry and electrochemical impedance
spectroscopy
Changes in the electrode impedance and voltammetry were mea-
sured in a stepwise fashion using CV and EIS in 5.0 mM [Fe(CN)6]3−/4−(Fig. 2) to monitor electrode modiﬁcation. CV shows a signiﬁcant shift
in the peakpotential aftermodiﬁcationwith ssDNAas a result of the com-
bination of electrostatic repulsion between the anionic DNA and redox
probes and the barrier created by the adsorbed organic layer. The ΔEp
of the bare electrode was 0.175 V, while theΔEp of ssDNAmodiﬁed elec-
trode was 0.395 V. Upon electrode modiﬁcation with ssDNA-anti-CRP
and subsequent CRP binding, the ΔEp shifted further to ΔEp 0.487 V and
ΔEp 0.561 V, respectively, indicative of the further increase in the thick-
ness of the organic layer (Fig. 2A). The changes in peak potential clearly
indicate successful DNA hybridization and protein capture on the
electrode.
EIS was also used to conﬁrm electrode modiﬁcation. Each point of
the Nyquist plot represents the impedance of one frequency scanned
from high to low. The semicircle of the Nyquist plot at low frequency
represents the charge transfer resistance (Rct). DNA hybridization or
protein capture on the electrode surface causes a change in Rct. From
the results in Fig. 2B, it can be observed that the Z′ of the self-
assembled monolayer (SAM) functionalized electrode (44.67 kΩ) was
larger than the Z′ of the bare gold electrode (1170 Ω). The impedance
increase indicates the successful modiﬁcation by SH-ssDNA. When the
SH-ssDNA modiﬁed electrode was hybridized with the ssDNA-anti-
CRP, the Rct value increased further due to increased blocking of the
electrode surface to the redox probe (59.53 kΩ). Finally, when CRP
was conjugated to the immobilized anti-CRP, an additional increase in
Fig. 3. (A) Fluorescence assay of ssDNA-anti-CRP hybridization, left: Au/ssDNA-anti-CRP-FITC (control), right: Au/dsDNA-anti-CRP-FITC and (B) CRP capture on goldmicrowire electrode
left: Au/FITC-CRP (control) right: Au/dsDNA-anti-CRP/FITC-CRP.
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and 25 mg/L CRP, respectively. The increase in Rct demonstrated bind-
ing of CRP to anti-CRP, resulting in an increase in Rct.
3.2. Fluorescence assay for ssDNA-anti-CRP hybridization and CRP capture
on gold microwire electrode
To further verify electrode modiﬁcation, a simple ﬂuorescence
assay was developed. The gold microwire electrode was ﬁrst modi-
ﬁed with SH-ssDNA. Then, FITC labeled ssDNA-anti-CRP was allowed
to hybridize with ssDNA on the electrode. Fluorescence was then
measured using a ﬂuorescence microscope (100X magniﬁcation).
Fig. 3A clearly shows ﬂuorescence from the gold electrode indicating
successful hybridization. Next, the experiment was repeated using
unlabeled ssDNA-anti-CRP and FITC-labeled CRP. Fig. 3B shows
clear ﬂuorescence indicating FITC-CRP binding to modiﬁedFig. 4. Calibration curve of spiked CRP in human control serum detection on gold
microwire electrode; 5.0 mM [Fe(CN)6]3−/4-, frequency 0.1 Hz–100 kHz, amplitude
0.01 V, potential 0.2 V. (n= 3, R2 = 0.989). Inset: linear range of calibration curve.electrode. These results verify the electrochemical results measured
for each modiﬁcation step and clearly indicate the viability of the
method for selective detection.
3.3. Calibration curve and CRP detection in serum samples
The binding of CRP to anti-CRP was indicated by the change in Rct.
After demonstrating the ability of DNA-directed immobilization on
an electrode surface to localize anti-CRP on an electrode surface, a
calibration curve was generated. CRP levels in control serum were
analyzed by EIS. After modiﬁcation, the electrodes were incubated
with the sample to allow CRP binding to anti-CRP. After thorough
rinsing, impedance spectra were obtained the presence of 5 mM
[Fe(CN)6]3−/4- in PBS. EIS data was normalized by using the equation
following R. K. Gupta [30]:
Δ Rct ¼ Rct dsDNA−anti−CRP=CRP
Rct dsDNA−anti−CRP
 
−1
Fig. 4 shows a plot of ΔRct versus CRP concentrations. The ΔRct in-
creased proportionally to CRP concentration. As thehigh CRP concentra-
tion increased, the measured Rct value increased. The graph became
non-linear at 50mg/L. The reason for this phenomenon is the excess an-
alyte concentration on the electrode surface, resulting in surface binding
site saturation on the microelectrodes. A linear range of 3.125–25 mg/L
for CRP detection by EIS was demonstrated (Inset of Fig. 4). The linearTable 1
CRP detection in serum samples.
Sample Spiked CRP concentration (mg/L) CRP concentration by EIS (mg/L)
1 5 6.07 ± 0.76
2 10 10.53 ± 1.68
3 20 19.02 ± 3.00
18 T. Songjaroen et al. / Sensing and Bio-Sensing Research 8 (2016) 14–19regressionwas y=0.0067×+0.0502, (R2=0.989). Blind CRP samples
were then analyzed using the sensor system with the results shown in
Table 1. The result from Table 1 shows that the CRP concentration ana-
lyzed by EIS method is correlated with the spiked CRP concentration.
4. Conclusions
A label-free electrochemical biosensor using DNA-directed immobi-
lization for C-reactive protein detection has been developed. Au
microwire electrodes were used as working electrodes because of the
ease of their incorporation in microﬂuidic devices. Electrochemical im-
pedance spectroscopy and cyclic voltammetry were used to follow the
electrode surface modiﬁcation processes with each step increasing the
faradaic impedance of the system. Finally, the systemwas used to detect
CRP in human control serum samples as an example application. Future
work will focus on addition of the biosensor for multiple targets of in-
ﬂammation and cardiovascular disease to microﬂuidic devices for
rapid, point-of-care screening.
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